DEXCOM INC·4

Mar 11, 6:30 PM ET

Brown Michael Jon 4

4 · DEXCOM INC · Filed Mar 11, 2024

Insider Transaction Report

Form 4
Period: 2024-03-08
Brown Michael Jon
EVP, Chief Legal Officer
Transactions
  • Award

    Common Stock

    2024-03-08+21,71180,105 total
Footnotes (2)
  • [F1]Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
  • [F2]Included in this number are 60,303 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 24,080 of which were granted on March 8, 2022 and shall vest through March 8, 2026.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT